Through a CPRIT Prevention award, UT Health Science Center at San Antonio is bringing genetic counseling and testing services to areas of Texas never before reached.
With a CPRIT Research award, Texas Tech University Health Science Center at El Paso is helping patients access cutting-edge clinical trials.
Cancer is the leading cause of death for Asian Americans. With a prevention grant from CPRIT, Light & Salt Association is working to equip communities with education and access to screening that can save lives.
With a research grant from CPRIT, scientists at the University of Texas Health Science Center at San Antonio are studying risk factors associated with increased liver cancer rates in South Texas.
Through a CPRIT Prevention award, health educators at Centro San Vicente of El Paso are empowering patients to take charge of their cancer screening needs.
Motivated by his experience as a pediatric brain tumor survivor, CPRIT Scholar Dr. Ryan Potts studies the biochemical and molecular mechanisms behind cancer cell formation.
Adolescent and young adult (AYA) cancer survivors participating in Seton Healthcare Family's ACCESS-AYA grant from CPRIT. The grant educates survivors and providers about the unique needs of AYAs.
Scientists at the University of Texas at El Paso are developing a novel therapy to treat both early and late stage prostate cancer.
Dr. Conrad Lyford of Texas Tech University discusses a unique public-private partnership made possible by a CPRIT Prevention award to promote cancer prevention in rural communities.
Dr. DeBerardinis of UT Southwestern Medical Center shares how a CPRIT Research award has lead to discovery of unique metabolic pathways that enable tumor growth.
Dr. Susan Campbell of the Cooper Institute discusses how a CPRIT Prevention award is empowering health care professionals, the public, and communities to fight obesity and reduce cancer risk.
19-year-old James Ragan is a student at Rice University, golfer, and founder of Triumph Over Kid Cancer Foundation. James is currently battling osteosarcoma, a type of cancer that starts in the bones, typically during adolescence.
Professor of Radiology at UT Southwestern Medical Center and CPRIT Research Award Recipient discusses the role of imaging to evaluate the effectiveness of a new cancer treatment.